Salt Lake Life Science Angels

Tute Genomics is a cloud-based clinical genome interpretation platform that enables researchers and clinicians to utilize human genome data for scientific discovery and individualized treatment. It has developed the most advanced analytical methods for genome analysis by incorporating proprietary machine-learning algorithms into a cloud-based application that allows researchers to analyze and interpret entire human genomes and discover genes and biomarkers at an unprecedented rate. It was founded in 2012 and headquartered in Provo, Utah.

Olive Medical Corporation, a Salt Lake City, UT based medical device manufacturing company, is dedicated to providing affordable HD MIS imaging equipment to the OR. The TCK1 HD Camera Head and OVB1 HD Camera Control Unit introduces affordable “True HD” MIS visualization with intuitive controls and light weight ergonomics. Using a combination of superior technology, cutting-edge imaging sensors and lean manufacturing processes, Olive Medical’s visualization system fits all cost containment needs. Olive Medical manufacturing is based in the United States.

VisualShare, Inc. specializes in SaaS-based software solutions designed for image exchange, management, and collaboration across various sectors, including medical, biomedical, life sciences, and pathology. The company's flagship product, VisualShare, provides a web-based platform that facilitates the sharing and management of images, enabling users such as investigators, lab managers, and medical professionals to document results, conduct reviews, and track experimental specimens. VisualShare's technology supports telehealth applications, allowing collaboration among geographically distant communities by consolidating all collected information into a single record for various stakeholder needs, including quality assurance and audit purposes. Based in Salt Lake City, Utah, VisualShare operates as a subsidiary of XIFIN, Inc., and has licensed innovative technology from the University of Utah, retaining rights to its developed derivatives.

MediProPharma, Inc. operates as a biotechnology company. The company was incorporated in 2006 and is based in Midvale, Utah.

Q Therapeutics, Inc. is a clinical-stage company focused on developing human cell-based therapies for neurodegenerative diseases affecting the brain and spinal cord. The company's primary product candidate, Q-Cells, consists of healthy human glial progenitor cells designed to restore or maintain normal neuronal activity by providing essential support functions typical of healthy central nervous system tissues. Q Therapeutics is working on applications of Q-Cells for various conditions, including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and traumatic spinal cord injuries, among others. Additionally, the company has a proprietary pipeline that includes neural cell products derived from induced pluripotent stem cells. Q Therapeutics is engaged in research collaborations aimed at enhancing its therapeutic offerings, including partnerships with ReproCELL for iPS cell therapies and InVivo Therapeutics for evaluating combined treatment approaches. Headquartered in Salt Lake City, Utah, Q Therapeutics was formerly known as Q Holdings, Inc. until its name change in December 2012.